Connect with us


Supreme Court extends pause in decision to restrict access to abortion pills



WASHINGTON. On Wednesday, the Supreme Court extended a two-day pause on a lower court decision that sought to limit access to the abortion pill mifepristone, ensuring the drug remains widely available for the time being.

In a brief ruling, Judge Samuel A. Alito, Jr. announced that the recess would end Friday at midnight, giving the court more time to hear the case, although it could act before then.

The fact that the court missed the earlier deadline suggests there may be disagreement among judges in its first major abortion access case, since a conservative majority overturned the constitutional right to abortion in June. It may also indicate that there may be disagreements in the case.

This is the decision of Judge Matthew J. Kachsmarik of the Northern District of Texas, who in recent weeks invalidated the Food and Drug Administration’s approval of mifepristone, part of the most commonly used abortion method in the United States.

The court ruling slows down the confusing and rapidly changing mifepristone landscape, marked by conflicting Federal District Court decisions and an appeals panel decision that further complicated the drug’s legal status.

After the Supreme Court overturned Roe v. Wade, a landmark 1973 case, in June the political and legal battles centered around abortion drugs. In some conservative states, lawmakers have made targeted pills.

Medical abortion, a two-component regimen, is usually used in the first 12 weeks of pregnancy. The first drug, mifepristone, blocks progesterone, a hormone that promotes pregnancy, and the second, misoprostol, taken one or two days later, causes contractions and helps the uterus expel its contents.

The controversy began in Texas in November, when an umbrella group of medical organizations and several anti-abortion doctors sued the FDA, challenging its approval of the pill more than two decades ago.

In their lawsuit, anti-abortion groups said the FDA did not follow proper protocols when it approved the drug in 2000. The groups said the agency has also ignored the dangers of the drug since then.

The Food and Drug Administration (FDA), which has vigorously countered these claims, said the drug was properly approved over 20 years ago and is very safe. He cited years of scientific research showing that serious complications are rare and that less than 1 percent of patients require hospitalization.

The lawsuit was filed in the Amarillo Division of the U.S. District Court for the Northern District of Texas, where the case is heard by a single federal judge, Judge Kachsmarik, appointed by President Donald Trump.

Judge Kaczmarik, a longtime anti-abortion advocate, is a former lawyer for the First Freedom Institute, a religious freedom legal group that has long supported conservative views.

This month, Judge Kaczmarik announced a preliminary ruling that voided the FDA’s approval for the drug. But the judge said the agency has a week to seek emergency help before his decision goes into effect.

Judge Kaczmarik filled his decision with the language of the anti-abortion movement, calling abortion providers “abortions” and a fetus or embryo “an unborn person” or “an unborn child.” He appears to have agreed with virtually all of the claims made by anti-abortion groups.

Less than an hour later, another federal judge, Thomas O. Rice, appointed by President Barack Obama, delivered a controversial ruling in Washington State in another case. Judge Rice has barred the FDA from restricting the availability of mifepristone in much of the country.

The Washington State lawsuit, filed by Democratic attorneys general in 17 states and the District of Columbia, is a direct challenge to the Texas case.

The Biden administration immediately appealed the federal judge’s decision in Texas, and a three-judge division of the New Orleans-based U.S. Court of Appeals for the Fifth Circuit announced that mifepristone can remain legal and available while the lawsuit is pending. your way through the courts.

The panel rejected Judge Kaczmarik’s conclusion that the FDA approval of mifepristone was invalid. At the same time, judges have blocked recent moves by the FDA to make the drug more affordable, including allowing pills to be mailed.

The next day, Judge Rice upheld his decision, ordering the FDA to maintain the status quo in 18 jurisdictions, adding further confusion over the availability of abortion pills.

The duel orders virtually guaranteed that the case would go to the Supreme Court.

The Biden administration, seeking emergency help, has asked judges to suspend a lower court ruling aimed at restricting access to the pill. In its summary, the government argued that the decision had serious implications not only for access to abortion pills, but for the pharmaceutical industry as a whole.

The government said that if the decision goes into effect, it will “change the regulatory regime for mifepristone.”

In their brief, the anti-abortion groups that filed the lawsuit alleged that “for nearly a quarter of a century” the FDA and the drug’s manufacturer, Danco Laboratories, “brazenly disregarded the law and applicable regulations, ignored holes and red flags in their own safety data, deliberately evaded judicial scrutiny and consistently put politics ahead of women’s health.”

The government and Danko stressed how consistent the lower court orders would be if they remained in place.

“In the absence of a suspension, the unprecedented nationwide lower court rulings would violate the regulatory regime for a drug that the FDA determined was safe and effective under approved conditions and that has been used by more than five million American women over the past two decades,” Solicitor General Elizabeth B. Prelogar, representing the FDA, wrote in a second letter.

Danco Laboratories stated in its response that the plaintiffs’ argument “will radically rewrite existing jurisprudence”.

“If this lawsuit was about any other drug, there would be no dispute that a group of doctors, [1] do not appoint him [2] Relying on the statistical possibility of meeting a patient in need of follow-up care would be inappropriate,” the statement said.

Adam Liptak another Pam Bellak made a report.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Cheryl Hines Endorses Robert F. Kennedy Jr. for President



Actress Cheryl Hines has said she supports her husband Robert F. Kennedy Jr.’s candidacy for president, despite evidence that they had previously disagreed on some issues.

Hello announced his plan to run for the 2024 Democratic presidential nomination on Wednesday in Boston, saying his “mission over the next 18 months of this campaign and throughout my presidency will be to end the corrupt merging of state and corporate power that now threatens to impose a new kind of corporate feudalism on our country.”

“My husband, Robert Kennedy Jr., announced today that he will be running for president and I support his decision,” the 57-year-old Curb Your Enthusiasm star said in a statement, adding that he“A fearless leader who understands the needs of the American people and has dedicated his life to fighting for democracy.”

Hines did not always support all of her husband’s views.

Although Kennedy was once known primarily as an environmental lawyer, over the past two decades he has become better known as one of the leading voices of the anti-vaccine movement.

As a result, he was called out by family and friends for his views, such as in 2019 when two siblings and a niece said political that Kennedy was part of a “campaign to attack institutions designed to lessen the tragedy of preventable infectious disease.”

Kennedy’s sister, Kerry Kennedy, who heads Robert F. Kennedy Human Rights, an international human rights group founded by their mother, Ethel, told The Associated Press in a 2021 interview her brother is “completely mistaken in [the vaccine] problem and very dangerous.

But Hines also criticized the behavior of her husband, whom she has been married to since 2014.

In January 2022, Robert F. Kennedy Jr. came under fire after compared the experience of anti-vaxxers to the victims of the Holocaust and referenced Anne Frank during a rally against vaccination mandates in Washington, DC.

in reply Hines reported this to a Twitter user.“My husband’s opinion is not a reflection of my own. Although we love each other, we disagree on many current issues.”

She later condemned his remarks, saying that the reference to Anne Frank was “reprehensible and tactless”.

She added: “The atrocities suffered by millions of people during the Holocaust should never be compared to anyone or anything. His opinion is not a reflection of my own.”

Despite this obvious fact, many Twitter users felt compelled to refer to her in their tweets about the Robert F. Kennedy Jr. announcement.

Continue Reading


Tennessee 3 to visit Biden at the White House next week



Three Tennessee lawmakers, who are facing an expulsion vote after participating in protests against the Nashville school shooting last month, will visit the White House to meet with President Joe Biden on Monday.

Karine Jean-Pierre’s spokeswoman announced the visit on Wednesday. She said Biden was “proud” and “grateful” that tri-state officials called for stricter gun restrictions, especially a ban on so-called assault weapons.

The president spoke to lawmakers to thank them “for speaking out and standing up for their position and for being clear about what is needed to protect their communities,” Jean-Pierre said.

The expulsion votes added a level of political drama and controversy to the violence at Testament School, where three children and three adults were killed.

Two deputies – Rep. Justin Pearson and Rep. Justin Jones, both blacks – were expelled by the Republican-controlled legislature. The third, Rep. Gloria Johnson, you never know.


From left: Rep. Justin Pearson, D-Memphis, Rep. Gloria Johnson, D-Knoxville, Rep., and Rep. Justin Jones, D-Nashville, D-R, raise their fists as they walk the Fisk University campus after Vice President Kamala Harris’ speech . April 7, 2023 in Nashville, Tennessee. (AP Photo/George Walker IV)


Pearson and Jones have since been reinstated by the local authorities, returning them to their positions on a temporary basis.

The state has set August 3 as the date for the special election for seats filled by Jones and Pearson, preceded by the June 15 primary. Both deputies announced that they intended to run.

Julia Brook, secretary of the Tennessee state office, said local officials believe it would cost about $120,000 to administer a special election in Nashville and between $375,000 and $500,000 in Memphis.

Vice President Kamala Harris visited Nashville earlier this month to support the Tennessee Three and their calls for greater gun control.

“Let’s not fall for the false choice – either you are for the Second Amendment or you need reasonable gun safety laws,” Harris said. “We can and should do both.”

Continue Reading


UK Cryptocurrency Regulation (and MiCA)



Barney Reynolds of Shearman & Sterling talks about the UK’s approach to cryptocurrencies and how it differs from the EU’s.

More about fintech:

Cryptocurrency regulation after the UK (and MiCA) first appeared on roll call.

Continue Reading


Copyright © 2023 Millennial One Media.